Quote:
Originally Posted by jfman
Just as Canada suspend use of the Astrazenica vaccine for under 55s the state propoganda machine have yet another puff piece about plucky upstarts Astrazenica being hard done by. It's almost as if they're prepared in advance.
https://www.bbc.co.uk/news/business-56570364
I'm quite sure a £94bn business isn't going to be exiting what's likely to be a huge money making market for the next few years.
While the vaccine is being supplied "at cost" for now there's no commitment to provide the likely ongoing annual boosters on that basis. I'm sure the Ugandans want to know why they're paying $8 compared to the EU paying $2 per shot also. |
Refrigerated transportation costs? Plus are some of the EU per dose costs offset by their capital investment?